To amend the Federal Food, Drug, and Cosmetic Act relating to the distribution chain of prescription drugs.

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 108th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

R Ann EmersonSponsor

23 cosponsors · 10 D, 12 R, 1 I

1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

Amends the Federal Food, Drug, and Cosmetic Act to require the wholesale distributor of certain drugs who is not the manufacturer or an authorized distributor of record for a calendar year of a drug to provide to the recipient of the drug a statement identifying each prior sale, purchase, or trade of such drug (currently, the language "for a calendar year"…

What it does: CRS summary · Introduced in House · May 22, 2003

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: To amend the Federal Food, Drug, and Cosmetic Act relating to the distribution chain of prescription drugs.

Latest action (Jun 2, 2003): Referred to the Subcommittee on Health.

Policy area: Health · Origin: House · Introduced: May 22, 2003

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.